This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Auto-Injectors Market

Auto-Injectors: A Better, Safe, And User-Friendly Drug Delivery Technology! Explore More with FMI

Auto-Injectors Market by Product, Indication, Distribution Channel & Region - Forecast 2022 – 2032

Auto-Injectors Market Outlook (2022-2032)

[276 Pages Report] The global auto-injectors market is expected to enjoy a valuation of US$ 3.5 Bn in 2022, and is further expected to expand at an impressive CAGR of 21.4% between 2022 and 2032, to reach a valuation of ~US$ 23.9 Bn 2032. Rising prevalence of various diseases including diabetes, anaphylaxis, and multiple sclerosis and increase in self administration of drugs are some of the key factors driving demand for auto-injectors in the market.

Based on the products, prefilled auto-injectors segment dominated the global autoinjector market with a share of about 91.7% in 2021 and the trend is likely to continue even during the forecast period.

Attribute

Key Statistics

Auto-Injectors Market Base Value (2021)

US$ 3.1 Bn

Estimated Market Size (2022)

US$ 3.5 Bn

Projected Market Size (2032)

US$ 23.9 Bn

Value-based CAGR (2022-2032)

21.4%

Market Share of Top 5 Countries

84.4%

Auto-injector devices are medical devices that are used to deliver a dose of a particular drug. They are very helpful in lowering the dependency on medical professionals to some extent. These specialized medical devices can be used to reduce the injuries related to the needle stick and help in reducing the phobia due to the needle that is quite common among patients. They are being preferred over traditional drug delivery systems due to their various advantages including user-friendliness, better accuracy, and less pain

Autoinjectors act as an aid in ensuring painless drug delivery of the complete dosage. Due to the convenience that these autoinjectors provide to the patients, the auto-injectors market is anticipated to grow at a marvellous pace during the assessment period.

With global burden of chronic diseases continuing to surge rapidly, people are opting for various novel treatments to manage and treat these diseases as well as to relieve symptoms. However, traditional drug delivery methods or systems are time consuming, cumbersome, inconvenient, and painful. As a result, people are looking for better and advanced drug delivery systems like autoinjectors.

Rapid surge in chronic diseases and growing trend of administering medical products like insulin at homes will continue to boost market growth during the assessment period.

Customize this Report

Let us know your requirement to get
100% FREE customization

Sales Analysis of Auto-Injectors from 2014 to 2021 Vs Market Outlook for 2022 to 2032

The global sales of auto-injectors grew at a CAGR of around 14.4% during the historical period of 2014 and 2021, and totalled a valuation of US$ 3.1 Bn in 2021. However, with rapid shift towards advanced and user-friendly drug delivery systems, the overall demand for autoinjectors is slated to grow at 21.4% CAGR between 2022 and 2032.

Auto-injectors have been preferred over conventional devices because they provide benefits such as easy self-administration, improved patient compliance, dosage accuracy, reduce the risk of needlestick injuries, and are easy to use. They have become ideal self-injectable devices worldwide.

The innovative designs of the autoinjectors have helped in enhancing efficiency concerning drug delivery. They have become more suitable for patients who require self-injections on a daily or weekly basis. Increasing demand for self-administration devices for the management and treatment of various indications across the globe is expected to boost revenue growth in the auto-injector devices market.

Auto-injectors are quite convenient in providing various advantages to patients. These advantages include ease of use and fast and simple administration during emergency as well as non-emergency environments. Devices such as autoinjectors and pen injectors are rising to prominence because of their user-friendly nature.

Similarly, technological advancements are opening the way for autoinjector devices that assure minimum error rates for first-time patients while also ensuring exact dosage of the drug that the patient wishes to self-administer. This will have a beneficial impact on the growth of the auto-injectors market.

The rising prevalence of chronic illnesses across the globe will continue to act as a catalyst triggering the growth of auto-injectors market. Chronic diseases majorly lead to an increasing number of deaths and an increasing number of disabled patients, worldwide. According to the World Health Organization (WHO), most chronic diseases were projected to lead to 73% of all deaths and 60% of the global burden of diseases. For example, multiple sclerosis, which is a chronic autoimmune disorder, is progressively increasing in developed countries like the U.S. As per the findings from the National Multiple Sclerosis Society, it was reported that around 1 million people in the U.S. were living with multiple sclerosis in 2019. This is a plus point for the growth of the auto-injectors market.

Auto-Injectors Market Download Report Brochure

What are the Key Trends Driving the Auto-Injectors Market?

“Rise in Chronic Diseases and Growing Popularity of Point-of-Care Devices to Bolster Market Growth”

The global auto-injectors market is set to witness high growth rate, owing to the initiatives by the governments in developing nations, growing demand for point-of-care devices, and rising awareness among people regarding the benefits of autoinjectors over traditional drug delivery systems.

Auto-injectors are an easy and simplified version of syringes and involve self-administration of drugs. Drug dosage from an auto-injector is more controlled and consistent than from manual syringes.

Also, the user-friendliness of the auto-injectors, growing number of product launches with improved functionality in the marketplace etc., increasing focus on safety and efficacy, and rising prevalence of diseases such as multiple sclerosis and anaphylaxis are expected to propel sales of auto-injectors in the market during the forthcoming years.

Similarly, growing need for treating and managing diseases like rheumatoid arthritis, diabetes, multiple sclerosis, and other disorders will continue to drive the global autoinjectors market. According to the International Diabetes Federation, roughly 463 million people worldwide suffered from diabetes in 2019, with the figure expected to climb to 700 million by 2045.

Sabyasachi Ghosh
Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

What are the Factors Restraining Growth of the Auto-Injectors Market?

The strict regulatory approvals, premium pricing, and recall of the products are some of the factors expected to restrain market growth during the forecast period.

The global auto-injectors market is enriched with patented technologies. Major players are pacing up with advanced product development in the global auto-injectors market. Limited competition and complex development processes lead to higher prices of auto-injectors. As a result, autoinjectors are available in the global market at a higher cost as compared to the alternative product's pre-filled syringes.

Moreover, pre-marketing approval is a lengthy and expensive process that influences the growth of the market.

Country-wise Insights

What Makes the U.S. a Large Market for Auto-Injectors?

“Increasing Incidence of Diabetes and Anaphylaxis Fuelling Market Growth in the U.S.”

The U.S. dominated North American auto-injectors market with a total market share of about 91.8% in 2021 and is expected to continue to experience the same growth throughout the forecast period. Rising prevalence of diseases like anaphylaxis and diabetes, availability of advanced drug delivery systems, increasing healthcare spending and strong presence of leading autoinjector manufacturers are some of the key factors driving growth in the U.S. auto-injectors market.

Over the years, there has been a sharp rise in diseases such as diabetes and anaphylaxis in the U.S. For instance, as per the Centers for Disease Control and Prevention (CDC) there are over 37.3 million people with diabetes in the United States. In order to manage their blood sugar levels, these people are highly dependent on insulin shots.

Similarly, as per the study conducted by the Asthma and Allergy Foundation of America (AAFA), anaphylaxis, a life-threatening allergic reaction, is common in the U.S. and occurs in about one in 50 Americans.

Thus, rise in cases of these medical conditions across the country along with prolonged usage of medications to manage them will continue to boost growth of the auto-injectors market during the forecast period.

Similarly, presence of favorable reimbursement policies and rising number of regulatory approvals will further expand the U.S. auto-injections market size during the forecast period.

What Makes Canada a Highly Lucrative Market for Auto-Injectors?

Easy Accessibility to Autoinjectors Pushing Demand in Canadian Market”

Canada held approximately 8.2% share in the North American auto-injectors market in 2021 and is expected to witness a lucrative growth rate of 19.7% CAGR during the forecast period. Rising incidence of various chronic diseases, increasing health awareness among people, and growing popularity of auto-injectors for self-administration of various drugs are fuelling market growth in Canada.

EmeradeTM epinephrine auto-injectors are currently offered in pharmacies all over Canada, according to an October 2020 announcement from Bausch Health, Canada. Canadians now have a second epinephrine auto-injector option in the form of Emerade. Growing accessibility to auto-injector products will propel the overall market growth within the country.

What is the Demand Outlook for Auto-Injectors Market in Germany?

“Rising Usage of Auto-Injectors to Minimize the Risk of Needle Stick Injuries Fostering Market Growth in Germany”

As per FMI, the auto-injectors market in Germany is set to exhibit a CAGR of nearly 21.8% during the forecast period, owing to the rapid surge in life-threatening diseases, rising need for reducing needlestick injuries, and availability of advanced drug delivery products.

Germany is becoming increasingly popular when it comes to health and innovation. Increase in research and development and more focus on patented drug delivery technologies in the country will raise demand for the auto-injectors market.

Moreover, with established guidelines on patient safety and the rising prevalence of needle stick injuries, demand for autoinjectors is set to grow at a marvellous pace during the next ten years.

MarketNage
Become a MarketNgage Insider

A unified Market Research Subscription Platform, built for today's disparate research needs.

Category-wise Insights

Which Product is High in Demand in the Global Auto-Injectors Market?

“Prefilled Auto-Injectors Will Remain Highly-Sought After Products in 2022 & Beyond”

As per FMI, prefilled auto-injectors segment held a massive share of about 91.7% in the global auto-injectors market in 2021 and it is expected to grow at a stupendous CAGR of 21.6% during the forecast period. This can be attributed to the rising end user preference for prefilled autoinjectors over fillable ones due to easy self-administration, reduced anxiety, and dosage accuracy.

Prefilled medications improve patient safety by reducing the possibility of accidental needle stick injuries and harmful product exposure that can arise while drawing drugs from vials.

Prefilled injection is convenient for those patients that require parenteral administration of drugs on a daily/weekly basis and long-term treatment. As such, they prefer self-administrated devices as they do not have to remain dependent on doctors for each dosage.

By Indication, Which Segment Will Generate the Highest Revenues in the Auto-Injectors Market?

“Demand for Auto-Injectors Will Remain High for Anaphylaxis”

Anaphylaxis segment held a revenue share of around 88.9% in 2021 and is expected to grow at the highest CAGR during the forecast period. Increased incidence of anaphylactic shock, preference of the patients to opt for self-administration injection devices, and companies focussing to improve functionality to advance their products technologically are driving growth of this segment.

People with potentially serious allergies like anaphylaxis are often prescribed to always carry adrenaline auto-injectors. These adrenaline auto-injectors can effectively stop an anaphylactic reaction from becoming life threatening. Thus, rise in cases of anaphylaxis will continue to push the demand for auto-injectors during the forecast period.

Which Distribution Channel Benefits the Most with the Sales of Auto-Injectors Globally?

“Online Pharmacies To Witness Highest Auto-Injector Sales”

Online pharmacies held the highest market share value of 38.6% in the auto-injectors market during 2021. Easy availability of the products with wide varieties has made it easy for consumers to buy products online with affordability, propelling sales of the overall auto-injectors market.

People today are more inclined towards purchasing medications and drug delivery devices from online pharmacies to reduce the overall expenses and save their time. Besides this, these online pharmacies offer various discounts and home delivery options to woo customers. All these factors will position the online pharmacies segment as a dominant distribution channel in the market.

Competitive Landscape

Key manufacturers of autoinjectors are using strategies such as new product launches and approvals, mergers and acquisitions, partnerships and collaborations, and price reduction to increase their client base and gain a competitive edge in the market. For instance,

  • In September 2021, Owen Mumford Pharmaceutical Services, a division of Owen Mumford Ltd. launched its new Aidaptus auto-injector platform. The new device is a 2-step, spring-powered, single use auto-injector designed to accommodate both 1 mL and 2.25 mL prefilled glass syringes in the same base device.
  • In April 2022, Halozyme Therapeutics, Inc. and Antares Pharma, Inc. announced the signing of a formal agreement under which Halozyme will acquire Antares.
  • In June 2020, Mylan N.V. and Biocon Ltd. announced the U.S. Food and Drug Administration (FDA) approval of the New Drug Application (NDA) for SemgleeTM (insulin glargine injection), in the vial and pre-filled pen forms, to control high blood sugar in adults with type 2 diabetes and adult and paediatric patients with type 1 diabetes. Semglee contains the same amino acid sequence as Lantus from Sanofi and is licensed for the same indications.

Report Scope

Attribute

Details

Estimated Market Value (2022)

US$ 3.5 Bn

Projected Market Value (2032)

US$ 23.9 Bn

Anticipated Growth Rate (2022-2032)

21.4%

Forecast Period

2014-2021

Historical Data Available for

2022-2032

Market Analysis

US$ Mn for Value

Key Regions Covered

North America, Latin America, Europe, South Asia, East Asia, Oceania, and Middle East & Africa

Key Countries Covered

U.S., Canada, Brazil, Mexico, Argentina, U.K., Germany, Italy, Russia, Spain, France, BENELUX, India, Thailand, Indonesia, Malaysia, Japan, China, South Korea, Australia, New Zealand, Turkey, GCC, North Africa, and South Africa

Key Market Segments Covered

Product, Indication, Distribution Channel, and Region

Key Companies Profiled

  • Becton, Dickinson and Company
  • Sanofi
  • Pfizer, Inc
  • Mylan N.V.
  • Novartis AG
  • Bayer AG
  • Janssen Global Services, LLC
  • Antares Pharma, Inc.
  • Amgen Inc
  • Eli Lilly and Company
  • Teva Pharmaceutical
  • Merck KgaA
  • GlaxoSmithKline plc
  • Ypsomed
  • SHL Medical
  • Gerresheimer AG
  • Midas Pharma GmbH
  • Aptar Pharma
  • Solteam Medical
  • Stevanato Group
  • E3D
  • West Pharmaceutical Services, Inc

Report Coverage

Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives

Key Market Segments Covered in Auto-Injectors Industry Research

By Product:

  • Prefilled Auto-Injectors
  • Fillable Auto-Injectors

By Indication:

  • Anaphylaxis
  • Multiple Sclerosis
  • Rheumatoid Arthritis
  • Others

By Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Drug Stores

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa (MEA)

Frequently Asked Questions

The global auto-injectors market size reached US$ 3.1 Bn in 2021 and is set to touch a valuation of US$ 3.5 Bn in 2022.

The auto-injectors market is expected to reach US$ 23.9 Bn by the end of 2032, with overall sales rising at 21.4% CAGR throughout the forecast period.

Growing adoption of advanced products, rising geriatric population, and innovative product development are some of the key trends in shaping the auto-injectors market.

The U.S., Canada, China, Japan, and the U.K. are top countries driving demand for the auto-injectors.

The U.S. accounted for about 91.8% of the North American auto-injectors market in 2021.

Demand for auto-injectors in Japan is expected to grow at a CAGR of 21.3% over the next ten years.

China, Germany, and the U.S. are the key producers of auto-injectors.

Demand for auto-injectors in Latin America is expected to increase at 20.3% CAGR over the next ten years

Demand for auto-injectors in MEA is expected to rise at a CAGR of 14.3% during the forecast period.

Becton, Dickinson and Company, Sanofi, Pfizer, Inc, Mylan N.V., Novartis AG, Bayer AG, Janssen Global Services, LLC, Antares Pharma, Inc., Amgen Inc, Eli Lilly and Company., Teva Pharmaceutical, Merck KgaA, GlaxoSmithKline plc, Ypsomed, and SHL Medical are some of the key players in the auto-injectors industry.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand Side Trends

    1.3. Supply Side Trends

    1.4. Technology Roadmap

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

    2.3. Inclusions and Exclusions

3. Key Market Trends

    3.1. Key Trends Impacting the Market

    3.2. Product Innovation / Development Trends

4. Key Success Factors

    4.1. Epidemiology of Key Indication, By Region

    4.2. Pipeline Assessment

    4.3. Regulatory Scenario

    4.4. Reimbursement Landscape

    4.5. PESTEL analysis

    4.6. Porter’s analysis

5. Market Background

    5.1. Macro-Economic Factors

        5.1.1. Global GDP Growth Outlook

        5.1.2. Global Healthcare GDP Growth Overview

        5.1.3. Global GDP and Infrastructure Investment

        5.1.4. International Trade

        5.1.5. Global Syringes and Needles Market Overview

    5.2. Forecast Factors - Relevance & Impact

        5.2.1. Rising Prevalence of Anaphylactic Shocks.

        5.2.2. Increasing Awareness and Adoption of for Painless Injection.

        5.2.3. New Drug Launches with Auto-Injectors.

        5.2.4. Advancing Medical Technology and Developments of Auto-Injectors.

    5.3. Value Chain

        5.3.1. Raw Material Suppliers

        5.3.2. Product Manufacturers

        5.3.3. End Users

    5.4. Market Dynamics

        5.4.1. Drivers

        5.4.2. Restraints

        5.4.3. Opportunity Analysis

    5.5. Global Supply Demand Analysis

6. COVID-19 Crisis – Crisis Analysis

    6.1. COVID-19 and Impact Analysis

        6.1.1. By Product

        6.1.2. By Indication

        6.1.3. By Distribution Channel

        6.1.4. By Region

    6.2. 2021 Market Scenario

7. Global Market Volume (Units) Analysis 2014-2021 and Forecast, 2022–2032

    7.1. Historical Market Volume (Units) Analysis, 2014-2021

    7.2. Current and Future Market Volume (Units) Projections, 2022–2032

        7.2.1. Y-o-Y Growth Trend Analysis

8. Global Market - Pricing Analysis

    8.1. Regional Pricing Analysis By Product

    8.2. Pricing Break-up

        8.2.1. Manufacturer Level Pricing

        8.2.2. Distributor Level Pricing

    8.3. Global Average Pricing Analysis Benchmark

    8.4. Pricing Assumptions

9. Global Market Demand (in Value or Size in US$ Mn) Analysis 2014-2021 and Forecast, 2022–2032

    9.1. Historical Market Value (US$ Mn) Analysis, 2014-2021

    9.2. Current and Future Market Value (US$ Mn) Projections, 2022–2032

        9.2.1. Y-o-Y Growth Trend Analysis

        9.2.2. Absolute $ Opportunity Analysis

10. Global Market Analysis 2014-2021 and Forecast 2022–2032, by Product

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Product, 2014-2021

    10.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Product, 2022–2032

        10.3.1. Prefilled Auto-Injectors

        10.3.2. Fillable Auto-Injectors

    10.4. Market Attractiveness Analysis By Product

11. Global Market Analysis 2014-2021 and Forecast 2022–2032, by Indication

    11.1. Introduction / Key Findings

    11.2. Historical Market Size (US$ Mn) Analysis By Indication, 2014-2021

    11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Indication, 2022–2032

        11.3.1. Anaphylaxis

        11.3.2. Multiple Sclerosis

        11.3.3. Rheumatoid Arthritis

        11.3.4. Others

    11.4. Market Attractiveness Analysis By Indication

12. Global Market Analysis 2014-2021 and Forecast 2022–2032, by Distribution Channel

    12.1. Introduction / Key Findings

    12.2. Historical Market Size (US$ Mn) Analysis, By Distribution Channel, 2014-2021

    12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution Channel, 2022–2032

        12.3.1. Hospital Pharmacies

        12.3.2. Retail Pharmacies

        12.3.3. Online Pharmacies

        12.3.4. Drug Stores

    12.4. Market Attractiveness Analysis By Distribution Channel

13. Global Market Analysis 2014-2021 and Forecast 2022–2032, by Region

    13.1. Introduction

    13.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Region, 2014-2021

    13.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Region, 2022–2032

        13.3.1. North America

        13.3.2. Latin America

        13.3.3. Europe

        13.3.4. East Asia

        13.3.5. South Asia

        13.3.6. Oceania

        13.3.7. Middle East and Africa (MEA)

    13.4. Market Attractiveness Analysis By Region

14. North America Market Analysis 2014-2021 and Forecast 2022–2032

    14.1. Introduction

    14.2. Pricing Analysis

    14.3. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Market Taxonomy, 2014-2021

    14.4. Current and Future Market Size (US$ Mn) and Volume (Units) Forecast By Market Taxonomy, 2022–2032

        14.4.1. By Country

            14.4.1.1. U.S.

            14.4.1.2. Canada

        14.4.2. By Product

        14.4.3. By Indication

        14.4.4. By Distribution Channel

    14.5. Market Attractiveness Analysis

        14.5.1. By Country

        14.5.2. By Product

        14.5.3. By Indication

        14.5.4. By Distribution Channel

    14.6. Market Trends

    14.7. Key Market Participants - Intensity Mapping

    14.8. Drivers and Restraints - Impact Analysis

    14.9. Country Level Analysis & Forecast

        14.9.1. U.S. Market Analysis

            14.9.1.1. .Introduction

            14.9.1.2. Market Analysis and Forecast by Market Taxonomy

                14.9.1.2.1. By Product

                14.9.1.2.2. By Indication

                14.9.1.2.3. By Distribution Channel

        14.9.2. Canada Market Analysis

            14.9.2.1. Introduction

            14.9.2.2. Market Analysis and Forecast by Market Taxonomy

                14.9.2.2.1. By Product

                14.9.2.2.2. By Indication

                14.9.2.2.3. By Distribution Channel

15. Latin America Market Analysis 2014-2021 and Forecast 2022–2032

    15.1. Introduction

    15.2. Pricing Analysis

    15.3. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Market Taxonomy, 2014-2021

    15.4. Current and Future Market Size (US$ Mn) and Volume (Units) Forecast By Market Taxonomy, 2022–2032

        15.4.1. By Country

            15.4.1.1. Mexico

            15.4.1.2. Brazil

            15.4.1.3. Argentina

            15.4.1.4. Rest of Latin America

        15.4.2. By Product

        15.4.3. By Indication

        15.4.4. By Distribution Channel

    15.5. Market Attractiveness Analysis

        15.5.1. By Country

        15.5.2. By Product

        15.5.3. By Indication

        15.5.4. By Distribution Channel

    15.6. Market Trends

    15.7. Key Market Participants - Intensity Mapping

    15.8. Drivers and Restraints - Impact Analysis

    15.9. Country Level Analysis & Forecast

        15.9.1. Mexico Market Analysis

            15.9.1.1. Introduction

            15.9.1.2. Market Analysis and Forecast by Market Taxonomy

                15.9.1.2.1. By Product

                15.9.1.2.2. By Indication

                15.9.1.2.3. By Distribution Channel

        15.9.2. Brazil Market Analysis

            15.9.2.1. Introduction

            15.9.2.2. Market Analysis and Forecast by Market Taxonomy

                15.9.2.2.1. By Product

                15.9.2.2.2. By Indication

                15.9.2.2.3. By Distribution Channel

        15.9.3. Argentina Market Analysis

            15.9.3.1. Introduction

            15.9.3.2. Market Analysis and Forecast by Market Taxonomy

                15.9.3.2.1. By Product

                15.9.3.2.2. By Indication

                15.9.3.2.3. By Distribution Channel

16. Europe Market Analysis 2014-2021 and Forecast 2022–2032

    16.1. Introduction

    16.2. Pricing Analysis

    16.3. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Market Taxonomy, 2014-2021

    16.4. Current and Future Market Size (US$ Mn) and Volume (Units) Forecast By Market Taxonomy, 2022–2032

        16.4.1. By Country

            16.4.1.1. Germany

            16.4.1.2. Italy

            16.4.1.3. France

            16.4.1.4. U.K.

            16.4.1.5. Spain

            16.4.1.6. BENELUX

            16.4.1.7. Russia

            16.4.1.8. Rest of Europe

        16.4.2. By Product

        16.4.3. By Indication

        16.4.4. By Distribution Channel

    16.5. Market Attractiveness Analysis

        16.5.1. By Country

        16.5.2. By Product

        16.5.3. By Indication

        16.5.4. By Distribution Channel

    16.6. Market Trends

    16.7. Key Market Participants - Intensity Mapping

    16.8. Drivers and Restraints - Impact Analysis

    16.9. Country Level Analysis & Forecast

        16.9.1. Germany Market Analysis

            16.9.1.1. Introduction

            16.9.1.2. Market Analysis and Forecast by Market Taxonomy

                16.9.1.2.1. By Product

                16.9.1.2.2. By Indication

                16.9.1.2.3. By Distribution Channel

        16.9.2. Italy Market Analysis

            16.9.2.1. Introduction

            16.9.2.2. Market Analysis and Forecast by Market Taxonomy

                16.9.2.2.1. By Product

                16.9.2.2.2. By Indication

                16.9.2.2.3. By Distribution Channel

        16.9.3. France Market Analysis

            16.9.3.1. Introduction

            16.9.3.2. Market Analysis and Forecast by Market Taxonomy

                16.9.3.2.1. By Product

                16.9.3.2.2. By Indication

                16.9.3.2.3. By Distribution Channel

        16.9.4. U.K. Market Analysis

            16.9.4.1. Introduction

            16.9.4.2. Market Analysis and Forecast by Market Taxonomy

                16.9.4.2.1. By Product

                16.9.4.2.2. By Indication

                16.9.4.2.3. By Distribution Channel

        16.9.5. Spain Market Analysis

            16.9.5.1. Introduction

            16.9.5.2. Market Analysis and Forecast by Market Taxonomy

                16.9.5.2.1. By Product

                16.9.5.2.2. By Indication

                16.9.5.2.3. By Distribution Channel

        16.9.6. BENELUX Market Analysis

            16.9.6.1. Introduction

            16.9.6.2. Market Analysis and Forecast by Market Taxonomy

                16.9.6.2.1. By Product

                16.9.6.2.2. By Indication

                16.9.6.2.3. By Distribution Channel

        16.9.7. Russia Market Analysis

            16.9.7.1. Introduction

            16.9.7.2. Market Analysis and Forecast by Market Taxonomy

                16.9.7.2.1. By Product

                16.9.7.2.2. By Indication

                16.9.7.2.3. By Distribution Channel

17. South Asia Market Analysis 2014-2021 and Forecast 2022–2032

    17.1. Introduction

    17.2. Pricing Analysis

    17.3. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Market Taxonomy, 2014-2021

    17.4. Current and Future Market Size (US$ Mn) and Volume (Units) Forecast By Market Taxonomy, 2022–2032

        17.4.1. By Country

            17.4.1.1. India

            17.4.1.2. Indonesia

            17.4.1.3. Malaysia

            17.4.1.4. Thailand

            17.4.1.5. Rest of South Asia

        17.4.2. By Product

        17.4.3. By Indication

        17.4.4. By Distribution Channel

    17.5. Market Attractiveness Analysis

        17.5.1. By Country

        17.5.2. By Product

        17.5.3. By Indication

        17.5.4. By Distribution Channel

    17.6. Market Trends

    17.7. Key Market Participants - Intensity Mapping

    17.8. Drivers and Restraints - Impact Analysis

    17.9. Country Level Analysis & Forecast

        17.9.1. India Market Analysis

            17.9.1.1. Introduction

            17.9.1.2. Market Analysis and Forecast by Market Taxonomy

                17.9.1.2.1. By Product

                17.9.1.2.2. By Indication

                17.9.1.2.3. By Distribution Channel

        17.9.2. Indonesia Market Analysis

            17.9.2.1. Introduction

            17.9.2.2. Market Analysis and Forecast by Market Taxonomy

                17.9.2.2.1. By Product

                17.9.2.2.2. By Indication

                17.9.2.2.3. By Distribution Channel

        17.9.3. Malaysia Market Analysis

            17.9.3.1. Introduction

            17.9.3.2. Market Analysis and Forecast by Market Taxonomy

                17.9.3.2.1. By Product

                17.9.3.2.2. By Indication

                17.9.3.2.3. By Distribution Channel

        17.9.4. Thailand Market Analysis

            17.9.4.1. Introduction

            17.9.4.2. Market Analysis and Forecast by Market Taxonomy

                17.9.4.2.1. By Product

                17.9.4.2.2. By Indication

                17.9.4.2.3. By Distribution Channel

18. East Asia Market Analysis 2014-2021 and Forecast 2022–2032

    18.1. Introduction

    18.2. Pricing Analysis

    18.3. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Market Taxonomy, 2014-2021

    18.4. Current and Future Market Size (US$ Mn) and Volume (Units) Forecast By Market Taxonomy, 2022–2032

        18.4.1. By Country

            18.4.1.1. China

            18.4.1.2. Japan

            18.4.1.3. South Korea

        18.4.2. By Product

        18.4.3. By Indication

        18.4.4. By Distribution Channel

    18.5. Market Attractiveness Analysis

        18.5.1. By Country

        18.5.2. By Product

        18.5.3. By Indication

        18.5.4. By Distribution Channel

    18.6. Market Trends

    18.7. Key Market Participants - Intensity Mapping

    18.8. Drivers and Restraints - Impact Analysis

    18.9. Country Level Analysis & Forecast

        18.9.1. China Market Analysis

            18.9.1.1. Introduction

            18.9.1.2. Market Analysis and Forecast by Market Taxonomy

                18.9.1.2.1. By Product

                18.9.1.2.2. By Indication

                18.9.1.2.3. By Distribution Channel

        18.9.2. Japan Market Analysis

            18.9.2.1. Introduction

            18.9.2.2. Market Analysis and Forecast by Market Taxonomy

                18.9.2.2.1. By Product

                18.9.2.2.2. By Indication

                18.9.2.2.3. By Distribution Channel

        18.9.3. South Korea Market Analysis

            18.9.3.1. Introduction

            18.9.3.2. Market Analysis and Forecast by Market Taxonomy

                18.9.3.2.1. By Product

                18.9.3.2.2. By Indication

                18.9.3.2.3. By Distribution Channel

19. Oceania Market 2017-2021 and Forecast 2022-2032

    19.1. Introduction

    19.2. Pricing Analysis

    19.3. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Market Taxonomy, 2014-2021

    19.4. Current and Future Market Size (US$ Mn) and Volume (Units) Forecast By Market Taxonomy, 2022–2032

        19.4.1. By Country

            19.4.1.1. Australia

            19.4.1.2. New Zealand

        19.4.2. By Product

        19.4.3. By Indication

        19.4.4. By Distribution Channel

    19.5. Market Attractiveness Analysis

        19.5.1. By Country

        19.5.2. By Product

        19.5.3. By Indication

        19.5.4. By Distribution Channel

    19.6. Key Market Participants - Intensity Mapping

    19.7. Drivers and Restraints - Impact Analysis

    19.8. Country Level Analysis & Forecast

        19.8.1. Australia Market Analysis

            19.8.1.1. Introduction

            19.8.1.2. Market Analysis and Forecast by Market Taxonomy

                19.8.1.2.1. By Product

                19.8.1.2.2. By Indication

                19.8.1.2.3. By Distribution Channel

        19.8.2. New Zealand Market Analysis

            19.8.2.1. Introduction

            19.8.2.2. Market Analysis and Forecast by Market Taxonomy

                19.8.2.2.1. By Product

                19.8.2.2.2. By Indication

                19.8.2.2.3. By Distribution Channel

20. Middle East and Africa (MEA) Market Analysis 2014-2021 and Forecast 2022–2032

    20.1. Introduction

    20.2. Pricing Analysis

    20.3. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Market Taxonomy, 2014-2021

    20.4. Current and Future Market Size (US$ Mn) and Volume (Units) Forecast By Market Taxonomy, 2022–2032

        20.4.1. By Country

            20.4.1.1. GCC Countries

            20.4.1.2. Turkey

            20.4.1.3. South Africa

            20.4.1.4. North Africa

            20.4.1.5. Rest of Middle East and Africa

        20.4.2. By Product

        20.4.3. By Indication

        20.4.4. By Distribution Channel

    20.5. Market Attractiveness Analysis

        20.5.1. By Country

        20.5.2. By Product

        20.5.3. By Indication

        20.5.4. By Distribution Channel

    20.6. Market Trends

    20.7. Key Market Participants - Intensity Mapping

    20.8. Drivers and Restraints - Impact Analysis

    20.9. Country Level Analysis & Forecast

        20.9.1. GCC Countries Market Analysis

            20.9.1.1. Introduction

            20.9.1.2. Market Analysis and Forecast by Market Taxonomy

                20.9.1.2.1. By Product

                20.9.1.2.2. By Indication

                20.9.1.2.3. By Distribution Channel

        20.9.2. Turkey Market Analysis

            20.9.2.1. Introduction

            20.9.2.2. Market Analysis and Forecast by Market Taxonomy

                20.9.2.2.1. By Product

                20.9.2.2.2. By Indication

                20.9.2.2.3. By Distribution Channel

        20.9.3. South Africa Market Analysis

            20.9.3.1. Introduction

            20.9.3.2. Market Analysis and Forecast by Market Taxonomy

                20.9.3.2.1. By Product

                20.9.3.2.2. By Indication

                20.9.3.2.3. By Distribution Channel

        20.9.4. North Africa Market Analysis

            20.9.4.1. Introduction

            20.9.4.2. Market Analysis and Forecast by Market Taxonomy

                20.9.4.2.1. By Product

                20.9.4.2.2. By Indication

                20.9.4.2.3. By Distribution Channel

21. Market Structure Analysis

    21.1. Market Analysis by Tier of Companies

    21.2. Market Share Analysis of Top Players

    21.3. Market Presence Analysis

22. Competition Analysis

    22.1. Competition Dashboard

    22.2. Competition Benchmarking

    22.3. Competition Deep Dive

        22.3.1. Becton, Dickinson and Company

            22.3.1.1. Overview

            22.3.1.2. Product Portfolio

            22.3.1.3. Profitability by Market Segments (Product/Channel/Region)

            22.3.1.4. Sales Footprint

            22.3.1.5. SWOT Analysis

            22.3.1.6. Key Financials

            22.3.1.7. Strategy Overview

        22.3.2. Sanofi

            22.3.2.1. Overview

            22.3.2.2. Product Portfolio

            22.3.2.3. Profitability by Market Segments (Product/Channel/Region)

            22.3.2.4. Sales Footprint

            22.3.2.5. SWOT Analysis

            22.3.2.6. Key Financials

            22.3.2.7. Strategy Overview

        22.3.3. Pfizer, Inc.

            22.3.3.1. Overview

            22.3.3.2. Product Portfolio

            22.3.3.3. Profitability by Market Segments (Product/Channel/Region)

            22.3.3.4. Sales Footprint

            22.3.3.5. SWOT Analysis

            22.3.3.6. Key Financials

            22.3.3.7. Strategy Overview

        22.3.4. Mylan N.V.

            22.3.4.1. Overview

            22.3.4.2. Product Portfolio

            22.3.4.3. Profitability by Market Segments (Product/Channel/Region)

            22.3.4.4. Sales Footprint

            22.3.4.5. SWOT Analysis

            22.3.4.6. Key Financials

            22.3.4.7. Strategy Overview

        22.3.5. Novartis AG

            22.3.5.1. Overview

            22.3.5.2. Product Portfolio

            22.3.5.3. Profitability by Market Segments (Product/Channel/Region)

            22.3.5.4. Sales Footprint

            22.3.5.5. SWOT Analysis

            22.3.5.6. Key Financials

            22.3.5.7. Strategy Overview

        22.3.6. Bayer AG

            22.3.6.1. Overview

            22.3.6.2. Product Portfolio

            22.3.6.3. Profitability by Market Segments (Product/Channel/Region)

            22.3.6.4. Sales Footprint

            22.3.6.5. SWOT Analysis

            22.3.6.6. Key Financials

            22.3.6.7. Strategy Overview

        22.3.7. Janssen Global Services, LLC

            22.3.7.1. Overview

            22.3.7.2. Product Portfolio

            22.3.7.3. Profitability by Market Segments (Product/Channel/Region)

            22.3.7.4. Sales Footprint

            22.3.7.5. SWOT Analysis

            22.3.7.6. Key Financials

            22.3.7.7. Strategy Overview

        22.3.8. Antares Pharma, Inc.

            22.3.8.1. Overview

            22.3.8.2. Product Portfolio

            22.3.8.3. Profitability by Market Segments (Product/Channel/Region)

            22.3.8.4. Sales Footprint

            22.3.8.5. SWOT Analysis

            22.3.8.6. Key Financials

            22.3.8.7. Strategy Overview

        22.3.9. Amgen Inc.

            22.3.9.1. Overview

            22.3.9.2. Product Portfolio

            22.3.9.3. Profitability by Market Segments (Product/Channel/Region)

            22.3.9.4. Sales Footprint

            22.3.9.5. SWOT Analysis

            22.3.9.6. Key Financials

            22.3.9.7. Strategy Overview

        22.3.10. Eli Lilly and Company

            22.3.10.1. Overview

            22.3.10.2. Product Portfolio

            22.3.10.3. Profitability by Market Segments (Product/Channel/Region)

            22.3.10.4. Sales Footprint

            22.3.10.5. SWOT Analysis

            22.3.10.6. Key Financials

            22.3.10.7. Strategy Overview

        22.3.11. SHL Medical AG

            22.3.11.1. Overview

            22.3.11.2. Product Portfolio

            22.3.11.3. Profitability by Market Segments (Product/Channel/Region)

            22.3.11.4. Sales Footprint

            22.3.11.5. SWOT Analysis

            22.3.11.6. Key Financials

            22.3.11.7. Strategy Overview

        22.3.12. Bespak Europe Ltd

            22.3.12.1. Overview

            22.3.12.2. Product Portfolio

            22.3.12.3. Profitability by Market Segments (Product/Channel/Region)

            22.3.12.4. Sales Footprint

            22.3.12.5. SWOT Analysis

            22.3.12.6. Key Financials

            22.3.12.7. Strategy Overview

        22.3.13. Ypsomed AG

            22.3.13.1. Overview

            22.3.13.2. Product Portfolio

            22.3.13.3. Profitability by Market Segments (Product/Channel/Region)

            22.3.13.4. Sales Footprint

            22.3.13.5. SWOT Analysis

            22.3.13.6. Key Financials

            22.3.13.7. Strategy Overview

        22.3.14. Teva Pharmaceuticals USA, Inc.

            22.3.14.1. Overview

            22.3.14.2. Product Portfolio

            22.3.14.3. Profitability by Market Segments (Product/Channel/Region)

            22.3.14.4. Sales Footprint

            22.3.14.5. SWOT Analysis

            22.3.14.6. Key Financials

            22.3.14.7. Strategy Overview

        22.3.15. Gerresheimer AG

            22.3.15.1. Overview

            22.3.15.2. Product Portfolio

            22.3.15.3. Profitability by Market Segments (Product/Channel/Region)

            22.3.15.4. Sales Footprint

            22.3.15.5. SWOT Analysis

            22.3.15.6. Key Financials

            22.3.15.7. Strategy Overview

        22.3.16. Midas Pharma GmbH

            22.3.16.1. Overview

            22.3.16.2. Product Portfolio

            22.3.16.3. Profitability by Market Segments (Product/Channel/Region)

            22.3.16.4. Sales Footprint

            22.3.16.5. SWOT Analysis

            22.3.16.6. Key Financials

            22.3.16.7. Strategy Overview

        22.3.17. Aptar Pharma

            22.3.17.1. Overview

            22.3.17.2. Product Portfolio

            22.3.17.3. Profitability by Market Segments (Product/Channel/Region)

            22.3.17.4. Sales Footprint

            22.3.17.5. SWOT Analysis

            22.3.17.6. Key Financials

            22.3.17.7. Strategy Overview

        22.3.18. Solteam Medical

            22.3.18.1. Overview

            22.3.18.2. Product Portfolio

            22.3.18.3. Profitability by Market Segments (Product/Channel/Region)

            22.3.18.4. Sales Footprint

            22.3.18.5. SWOT Analysis

            22.3.18.6. Key Financials

            22.3.18.7. Strategy Overview

        22.3.19. Stevanato Group

            22.3.19.1. Overview

            22.3.19.2. Product Portfolio

            22.3.19.3. Profitability by Market Segments (Product/Channel/Region)

            22.3.19.4. Sales Footprint

            22.3.19.5. SWOT Analysis

            22.3.19.6. Key Financials

            22.3.19.7. Strategy Overview

        22.3.20. E3D

            22.3.20.1. Overview

            22.3.20.2. Product Portfolio

            22.3.20.3. Profitability by Market Segments (Product/Channel/Region)

            22.3.20.4. Sales Footprint

            22.3.20.5. SWOT Analysis

            22.3.20.6. Key Financials

            22.3.20.7. Strategy Overview

        22.3.21. West Pharmaceutical Services, Inc.

            22.3.21.1. Overview

            22.3.21.2. Product Portfolio

            22.3.21.3. Profitability by Market Segments (Product/Channel/Region)

            22.3.21.4. Sales Footprint

            22.3.21.5. SWOT Analysis

            22.3.21.6. Key Financials

            22.3.21.7. Strategy Overview

23. Assumptions and Acronyms Used

24. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 01: Global Market Value (US$ Mn) Analysis and Forecast 2014–2032, by Product

Table 02: Global Market Volume (Units) Analysis and Forecast 2014–2032, by Product

Table 03: Global Market Value (US$ Mn) Analysis and Forecast 2014–2032, by Indication

Table 04: Global Market Value (US$ Mn) Analysis and Forecast 2014–2032, by Distribution Channel

Table 05: Global Market Value (US$ Mn) Analysis and Forecast 2014–2032, by Region

Table 06: North America Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022–2032, by Country

Table 07: North America Market Value (US$ Mn) Analysis and Forecast 2014–2032, by Product

Table 08: North America Market Volume (Units) Analysis and Forecast 2014–2032, by Product

Table 09: North America Market Value (US$ Mn) Analysis and Forecast 2014–2032, by Indication

Table 10: North America Market Value (US$ Mn) Analysis and Forecast 2014–2032, by Distribution Channel

Table 11: Latin America Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022–2032, by Country

Table 12: Latin America Market Value (US$ Mn) Analysis and Forecast 2014–2032, by Product

Table 13: Latin America Market Volume (Units) Analysis and Forecast 2014–2032, by Product

Table 14: Latin America Market Value (US$ Mn) Analysis and Forecast 2014–2032, by Indication

Table 15: Latin America Market Value (US$ Mn) Analysis and Forecast 2014–2032, by Distribution Channel

Table 16: Europe Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022–2032, by Country

Table 17: Europe Market Value (US$ Mn) Analysis and Forecast 2014–2032, by Product

Table 18: Europe Market Volume (Units) Analysis and Forecast 2014–2032, by Product

Table 19: Europe Market Value (US$ Mn) Analysis and Forecast 2014–2032, by Indication

Table 20: Europe Market Value (US$ Mn) Analysis and Forecast 2014–2032, by Distribution Channel

Table 21: South Asia Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022–2032, by Country

Table 22: South Asia Market Value (US$ Mn) Analysis and Forecast 2014–2032, by Product

Table 23: South Asia Market Volume (Units) Analysis and Forecast 2014–2032, by Product

Table 24: South Asia Market Value (US$ Mn) Analysis and Forecast 2014–2032, by Indication

Table 25: South Asia Market Value (US$ Mn) Analysis and Forecast 2014–2032, by Distribution Channel

Table 26: East Asia Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022–2032, by Country

Table 27: East Asia Market Value (US$ Mn) Analysis and Forecast 2014–2032, by Product

Table 28: East Asia Market Volume (Units) Analysis and Forecast 2014–2032, by Product

Table 29: East Asia Market Value (US$ Mn) Analysis and Forecast 2014–2032, by Indication

Table 30: East Asia Market Value (US$ Mn) Analysis and Forecast 2014–2032, by Distribution Channel

Table 31: Oceania Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022–2032, by Country

Table 32: Oceania Market Value (US$ Mn) Analysis and Forecast 2014–2032, by Product

Table 33: Oceania Market Volume (Units) Analysis and Forecast 2014–2032, by Product

Table 34: Oceania Market Value (US$ Mn) Analysis and Forecast 2014–2032, by Indication

Table 35: Oceania Market Value (US$ Mn) Analysis and Forecast 2014–2032, by Distribution Channel

Table 36: MEA Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022–2032, by Country

Table 37: MEA Market Value (US$ Mn) Analysis and Forecast 2014–2032, by Product

Table 38: MEA Market Volume (Units) Analysis and Forecast 2014–2032, by Product

Table 39: MEA Market Value (US$ Mn) Analysis and Forecast 2014–2032, by Indication

Table 40: MEA Market Value (US$ Mn) Analysis and Forecast 2014–2032, by Distribution Channel

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 01: Global Market Volume (Units), 2014 – 2021

Figure 02: Global Market Volume (Units) & Y-o-Y Growth (%) Analysis, 2022–2032

Figure 03: Auto-Injectors, Pricing Analysis per unit (US$), in 2022

Figure 04: Auto-Injectors, Pricing Forecast per unit (US$), in 2032

Figure 05: Global Market Value (US$ Mn) Analysis, 2014–2021

Figure 06: Global Market Forecast & Y-o-Y Growth, 2022–2032

Figure 07: Global Market Absolute $ Opportunity (US$ Mn) Analysis, 2021–2032

Figure 08: Global Market Value Share (%) Analysis 2022 and 2032, by Product

Figure 09: Global Market Y-o-Y Growth (%) Analysis 2021-2032, by Product

Figure 10: Global Market Attractiveness Analysis 2022–2032, by Product

Figure 11: Global Market Value Share (%) Analysis 2022 and 2032, by Indication

Figure 12: Global Market Y-o-Y Growth (%) Analysis 2021-2032, by Indication

Figure 13: Global Market Attractiveness Analysis 2022–2032, by Indication

Figure 14: Global Market Value Share (%) Analysis 2022 and 2032, by Distribution Channel

Figure 15: Global Market Y-o-Y Growth (%) Analysis 2021-2032, by Distribution Channel

Figure 16: Global Market Attractiveness Analysis 2022–2032, by Distribution Channel

Figure 17: Global Market Value Share (%) Analysis 2022 and 2032, by Region

Figure 18: Global Market Y-o-Y Growth (%) Analysis 2021-2032, by Region

Figure 19: Global Market Attractiveness Analysis 2022–2032, by Region

Figure 20: North America Market Value (US$ Mn) Analysis, 2014–2021

Figure 21: North America Market Value (US$ Mn) Forecast, 2022-2032

Figure 22: North America Market Value Share, by Product (2022 E)

Figure 23: North America Market Value Share, by Indication (2022 E)

Figure 24: North America Market Value Share, by Distribution Channel (2022 E)

Figure 25: North America Market Value Share, by Country (2022 E)

Figure 26: North America Market Attractiveness Analysis by Product, 2022–2032

Figure 27: North America Market Attractiveness Analysis by Indication, 2022–2032

Figure 28: North America Market Attractiveness Analysis by Distribution Channel, 2022–2032

Figure 29: North America Market Attractiveness Analysis by Country, 2022–2032

Figure 30: U.S. Market Value Proportion Analysis, 2021

Figure 31: Global Vs. U.S. Growth Comparison

Figure 32: U.S. Market Share Analysis (%) by Product, 2021 & 2032

Figure 33: U.S. Market Share Analysis (%) by Indication, 2021 & 2032

Figure 34: U.S. Market Share Analysis (%) by Distribution Channel, 2021 & 2032

Figure 35: Canada Market Value Proportion Analysis, 2021

Figure 36: Global Vs. Canada. Growth Comparison

Figure 37: Canada Market Share Analysis (%) by Product, 2021 & 2032

Figure 38: Canada Market Share Analysis (%) by Indication, 2021 & 2032

Figure 39: Canada Market Share Analysis (%) by Distribution Channel, 2021 & 2032

Figure 40: Latin America Market Value (US$ Mn) Analysis, 2014–2021

Figure 41: Latin America Market Value (US$ Mn) Forecast, 2022-2032

Figure 42: Latin America Market Value Share, by Product (2022 E)

Figure 43: Latin America Market Value Share, by Indication (2022 E)

Figure 44: Latin America Market Value Share, by Distribution Channel (2022 E)

Figure 45: Latin America Market Value Share, by Country (2022 E)

Figure 46: Latin America Market Attractiveness Analysis by Product, 2022–2032

Figure 47: Latin America Market Attractiveness Analysis by Indication, 2022–2032

Figure 48: Latin America Market Attractiveness Analysis by Distribution Channel, 2022–2032

Figure 49: Latin America Market Attractiveness Analysis by Country, 2022–2032

Figure 50: Mexico Market Value Proportion Analysis, 2021

Figure 51: Global Vs Mexico Growth Comparison

Figure 52: Mexico Market Share Analysis (%) by Product, 2021 & 2032

Figure 53: Mexico Market Share Analysis (%) by Indication, 2021 & 2032

Figure 54: Mexico Market Share Analysis (%) by Distribution Channel, 2021 & 2032

Figure 55: Brazil Market Value Proportion Analysis, 2021

Figure 56: Global Vs. Brazil. Growth Comparison

Figure 57: Brazil Market Share Analysis (%) by Product, 2021 & 2032

Figure 58: Brazil Market Share Analysis (%) by Indication, 2021 & 2032

Figure 59: Brazil Market Share Analysis (%) by Distribution Channel, 2021 & 2032

Figure 60: Argentina Market Value Proportion Analysis, 2021

Figure 61: Global Vs Argentina Growth Comparison

Figure 62: Argentina Market Share Analysis (%) by Product, 2021 & 2032

Figure 63: Argentina Market Share Analysis (%) by Indication, 2021 & 2032

Figure 64: Argentina Market Share Analysis (%) by Distribution Channel, 2021 & 2032

Figure 65: Europe Market Value (US$ Mn) Analysis, 2014–2021

Figure 66: Europe Market Value (US$ Mn) Forecast, 2022-2032

Figure 67: Europe Market Value Share, by Product (2022 E)

Figure 68: Europe Market Value Share, by Indication (2022 E)

Figure 69: Europe Market Value Share, by Distribution Channel (2022 E)

Figure 70: Europe Market Value Share, by Country (2022 E)

Figure 71: Europe Market Attractiveness Analysis by Product, 2022–2032

Figure 72: Europe Market Attractiveness Analysis by Indication, 2022–2032

Figure 73: Europe Market Attractiveness Analysis by Distribution Channel, 2022–2032

Figure 74: Europe Market Attractiveness Analysis by Country, 2022–2032

Figure 75: UK Market Value Proportion Analysis, 2021

Figure 76: Global Vs. UK Growth Comparison

Figure 77: UK Market Share Analysis (%) by Product, 2021 & 2032

Figure 78: UK Market Share Analysis (%) by Indication, 2021 & 2032

Figure 79: UK Market Share Analysis (%) by Distribution Channel, 2021 & 2032

Figure 80: Germany Market Value Proportion Analysis, 2021

Figure 81: Global Vs. Germany Growth Comparison

Figure 82: Germany Market Share Analysis (%) by Product, 2021 & 2032

Figure 83: Germany Market Share Analysis (%) by Indication, 2021 & 2032

Figure 84: Germany Market Share Analysis (%) by Distribution Channel, 2021 & 2032

Figure 85: Italy Market Value Proportion Analysis, 2021

Figure 86: Global Vs. Italy Growth Comparison

Figure 87: Italy Market Share Analysis (%) by Product, 2021 & 2032

Figure 88: Italy Market Share Analysis (%) by Indication, 2021 & 2032

Figure 89: Italy Market Share Analysis (%) by Distribution Channel, 2021 & 2032

Figure 90: France Market Value Proportion Analysis, 2021

Figure 91: Global Vs France Growth Comparison

Figure 92: France Market Share Analysis (%) by Product, 2021 & 2032

Figure 93: France Market Share Analysis (%) by Indication, 2021 & 2032

Figure 94: France Market Share Analysis (%) by Distribution Channel, 2021 & 2032

Figure 95: Spain Market Value Proportion Analysis, 2021

Figure 96: Global Vs Spain Growth Comparison

Figure 97: Spain Market Share Analysis (%) by Product, 2021 & 2032

Figure 98: Spain Market Share Analysis (%) by Indication, 2021 & 2032

Figure 99: Spain Market Share Analysis (%) by Distribution Channel, 2021 & 2032

Figure 100: Russia Market Value Proportion Analysis, 2021

Figure 101: Global Vs Russia Growth Comparison

Figure 102: Russia Market Share Analysis (%) by Product, 2021 & 2032

Figure 103: Russia Market Share Analysis (%) by Indication, 2021 & 2032

Figure 104: Russia Market Share Analysis (%) by Distribution Channel, 2021 & 2032

Figure 105: BENELUX Market Value Proportion Analysis, 2021

Figure 106: Global Vs BENELUX Growth Comparison

Figure 107: BENELUX Market Share Analysis (%) by Product, 2021 & 2032

Figure 108: BENELUX Market Share Analysis (%) by Indication, 2021 & 2032

Figure 109: BENELUX Market Share Analysis (%) by Distribution Channel, 2021 & 2032

Figure 110: East Asia Market Value (US$ Mn) Analysis, 2014–2021

Figure 111: East Asia Market Value (US$ Mn) Forecast, 2022-2032

Figure 112: East Asia Market Value Share, by Product (2022 E)

Figure 113: East Asia Market Value Share, by Indication (2022 E)

Figure 114: East Asia Market Value Share, by Distribution Channel (2022 E)

Figure 115: East Asia Market Value Share, by Country (2022 E)

Figure 116: East Asia Market Attractiveness Analysis by Product, 2022–2032

Figure 117: East Asia Market Attractiveness Analysis by Indication, 2022–2032

Figure 118: East Asia Market Attractiveness Analysis by Distribution Channel, 2022–2032

Figure 119: East Asia Market Attractiveness Analysis by Country, 2022–2032

Figure 120: China Market Value Proportion Analysis, 2021

Figure 121: Global Vs. China Growth Comparison

Figure 122: China Market Share Analysis (%) by Product, 2021 & 2032

Figure 123: China Market Share Analysis (%) by Indication, 2021 & 2032

Figure 124: China Market Share Analysis (%) by Distribution Channel, 2021 & 2032

Figure 125: Japan Market Value Proportion Analysis, 2021

Figure 126: Global Vs. Japan Growth Comparison

Figure 127: Japan Market Share Analysis (%) by Product, 2021 & 2032

Figure 128: Japan Market Share Analysis (%) by Indication, 2021 & 2032

Figure 129: Japan Market Share Analysis (%) by Distribution Channel, 2021 & 2032

Figure 130: South Korea Market Value Proportion Analysis, 2021

Figure 131: Global Vs South Korea Growth Comparison

Figure 132: South Korea Market Share Analysis (%) by Product, 2021 & 2032

Figure 133: South Korea Market Share Analysis (%) by Indication, 2021 & 2032

Figure 134: South Korea Market Share Analysis (%) by Distribution Channel, 2021 & 2032

Figure 135: South Asia Market Value (US$ Mn) Analysis, 2014–2021

Figure 136: South Asia Market Value (US$ Mn) Forecast, 2022-2032

Figure 137: South Asia Market Value Share, by Product (2022 E)

Figure 138: South Asia Market Value Share, by Indication (2022 E)

Figure 139: South Asia Market Value Share, by Distribution Channel (2022 E)

Figure 140: South Asia Market Value Share, by Country (2022 E)

Figure 141: South Asia Market Attractiveness Analysis by Product, 2022–2032

Figure 142: South Asia Market Attractiveness Analysis by Indication, 2022–2032

Figure 143: South Asia Market Attractiveness Analysis by Distribution Channel, 2022–2032

Figure 144: South Asia Market Attractiveness Analysis by Country, 2022–2032

Figure 145: India Market Value Proportion Analysis, 2021

Figure 146: Global Vs. India Growth Comparison

Figure 147: India Market Share Analysis (%) by Product, 2021 & 2032

Figure 148: India Market Share Analysis (%) by Indication, 2021 & 2032

Figure 149: India Market Share Analysis (%) by Distribution Channel, 2021 & 2032

Figure 150: Indonesia Market Value Proportion Analysis, 2021

Figure 151: Global Vs. Indonesia Growth Comparison

Figure 152: Indonesia Market Share Analysis (%) by Product, 2021 & 2032

Figure 153: Indonesia Market Share Analysis (%) by Indication, 2021 & 2032

Figure 154: Indonesia Market Share Analysis (%) by Distribution Channel, 2021 & 2032

Figure 155: Malaysia Market Value Proportion Analysis, 2021

Figure 156: Global Vs. Malaysia Growth Comparison

Figure 157: Malaysia Market Share Analysis (%) by Product, 2021 & 2032

Figure 158: Malaysia Market Share Analysis (%) by Indication, 2021 & 2032

Figure 159: Malaysia Market Share Analysis (%) by Distribution Channel, 2021 & 2032

Figure 160: Thailand Market Value Proportion Analysis, 2021

Figure 161: Global Vs. Thailand Growth Comparison

Figure 162: Thailand Market Share Analysis (%) by Product, 2021 & 2032

Figure 163: Thailand Market Share Analysis (%) by Indication, 2021 & 2032

Figure 164: Thailand Market Share Analysis (%) by Distribution Channel, 2021 & 2032

Figure 165: Oceania Market Value (US$ Mn) Analysis, 2014–2021

Figure 166: Oceania Market Value (US$ Mn) Forecast, 2022-2032

Figure 167: Oceania Market Value Share, by Product (2022 E)

Figure 168: Oceania Market Value Share, by Indication (2022 E)

Figure 169: Oceania Market Value Share, by Distribution Channel (2022 E)

Figure 170: Oceania Market Value Share, by Country (2022 E)

Figure 171: Oceania Market Attractiveness Analysis by Product, 2022–2032

Figure 172: Oceania Market Attractiveness Analysis by Indication, 2022–2032

Figure 173: Oceania Market Attractiveness Analysis by Distribution Channel, 2022–2032

Figure 174: Oceania Market Attractiveness Analysis by Country, 2022–2032

Figure 175: Australia Market Value Proportion Analysis, 2021

Figure 176: Global Vs. Australia Growth Comparison

Figure 177: Australia Market Share Analysis (%) by Product, 2021 & 2032

Figure 178: Australia Market Share Analysis (%) by Indication, 2021 & 2032

Figure 179: Australia Market Share Analysis (%) by Distribution Channel, 2021 & 2032

Figure 180: New Zealand Market Value Proportion Analysis, 2021

Figure 181: Global Vs New Zealand Growth Comparison

Figure 182: New Zealand Market Share Analysis (%) by Product, 2021 & 2032

Figure 183: New Zealand Market Share Analysis (%) by Indication, 2021 & 2032

Figure 184: New Zealand Market Share Analysis (%) by Distribution Channel, 2021 & 2032

Figure 185: Middle East & Africa Market Value (US$ Mn) Analysis, 2014–2021

Figure 186: Middle East & Africa Market Value (US$ Mn) Forecast, 2022-2032

Figure 187: Middle East & Africa Market Value Share, by Product (2022 E)

Figure 188: Middle East & Africa Market Value Share, by Indication (2022 E)

Figure 189: Middle East & Africa Market Value Share, by Distribution Channel (2022 E)

Figure 190: Middle East & Africa Market Value Share, by Country (2022 E)

Figure 191: Middle East & Africa Market Attractiveness Analysis by Product, 2022–2032

Figure 192: Middle East & Africa Market Attractiveness Analysis by Indication, 2022–2032

Figure 193: Middle East & Africa Market Attractiveness Analysis by Distribution Channel, 2022–2032

Figure 194: Middle East & Africa Market Attractiveness Analysis by Country, 2022–2032

Figure 195: GCC Countries Market Value Proportion Analysis, 2021

Figure 196: Global Vs GCC Countries Growth Comparison

Figure 197: GCC Countries Market Share Analysis (%) by Product, 2021 & 2032

Figure 198: GCC Countries Market Share Analysis (%) by Indication, 2021 & 2032

Figure 199: GCC Countries Market Share Analysis (%) by Distribution Channel, 2021 & 2032

Figure 200: Turkey Market Value Proportion Analysis, 2021

Figure 201: Global Vs. Turkey Growth Comparison

Figure 202: Turkey Market Share Analysis (%) by Product, 2021 & 2032

Figure 203: Turkey Market Share Analysis (%) by Indication, 2021 & 2032

Figure 204: Turkey Market Share Analysis (%) by Distribution Channel, 2021 & 2032

Figure 205: South Africa Market Value Proportion Analysis, 2021

Figure 206: Global Vs. South Africa Growth Comparison

Figure 207: South Africa Market Share Analysis (%) by Product, 2021 & 2032

Figure 208: South Africa Market Share Analysis (%) by Indication, 2021 & 2032

Figure 209: South Africa Market Share Analysis (%) by Distribution Channel, 2021 & 2032

Figure 210: North Africa Market Value Proportion Analysis, 2021

Figure 211: Global Vs North Africa Growth Comparison

Figure 212: North Africa Market Share Analysis (%) by Product, 2021 & 2032

Figure 213: North Africa Market Share Analysis (%) by Indication, 2021 & 2032

Figure 214: North Africa Market Share Analysis (%) by Distribution Channel, 2021 & 2032

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Suture Needles Market

Published : May 2022

Healthcare

High Flow Needle Sets Market

Published : July 2019

Healthcare

Orthopedic Prosthetic Devices Market

Published : February 2022

Healthcare

Arthroscopy Devices Market

Published : February 2022

Google translate

Auto-Injectors Market